Literature DB >> 12638724

Hypothalamic-pituitary sarcoidosis with hypopituitarism. Long-term remission with methylprednisolone pulse therapy.

Ana Molina1, Juan Mañá, Carles Villabona, Miguel Fernández-Castañer, Juan Soler.   

Abstract

A 29-year-old man presented with diplopia and decreased strength in the left arm. A magnetic resonance image (MRI) showed an extensive hypothalamic and pituitary gland mass, and hormonal studies showed partial hypopituitarism and mild hyperprolactinemia without diabetes insipidus. Biopsies of the hypothalamic lesion and of a mediastinal lymph node demonstrated noncaseating granulomas, and a Kveim-Siltzbach test was positive. He was successfully treated with a regimen of high-dose intravenous methylprednisolone pulse therapy for eight weeks along with a low dose of oral corticosteroids which was maintained indefinitely. An MRI obtained immediately after pulse therapy revealed a substantial reduction in the hypothalamic-pituitary mass, which was maintained in an MRI performed 3 years later. However, hormonal deficits persisted and indefinite hormonal substitutive therapy was required.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12638724     DOI: 10.1023/a:1022153401880

Source DB:  PubMed          Journal:  Pituitary        ISSN: 1386-341X            Impact factor:   4.107


  12 in total

Review 1.  Endocrine aspects of sarcoidosis.

Authors:  J L Winnacker; K L Becker; S Katz
Journal:  N Engl J Med       Date:  1968-02-29       Impact factor: 91.245

2.  Hyperprolactinemia in sarcoidosis.

Authors:  R W Turkington; J H MacIndoe
Journal:  Ann Intern Med       Date:  1972-04       Impact factor: 25.391

3.  Neurosarcoidosis. A report of ten patients illustrating some usual and unusual manifestations.

Authors:  O P Sharma; A Anders
Journal:  Sarcoidosis       Date:  1985-09

4.  Intravenous pulse methyl prednisolone in the successful treatment of severe sarcoid polyneuropathy with pulmonary involvement.

Authors:  R K Allen; J Merory
Journal:  Aust N Z J Med       Date:  1985-02

5.  Hypothalamic-pituitary dysfunction with adrenal insufficiency and hyperprolactinaemia in sarcoidosis. A case report.

Authors:  T L Verhage; M H Godfried; C Alberts
Journal:  Sarcoidosis       Date:  1990-09

Review 6.  Cardiac and neurologic dysfunction in sarcoidosis.

Authors:  O P Sharma
Journal:  Clin Chest Med       Date:  1997-12       Impact factor: 2.878

7.  Neurosarcoidosis presenting as hypopituitarism and a cystic pituitary mass.

Authors:  M S Guoth; J Kim; A C de Lotbiniere; M L Brines
Journal:  Am J Med Sci       Date:  1998-03       Impact factor: 2.378

8.  Intrasellar mass with hypopituitarism as a manifestation of sarcoidosis. Case report.

Authors:  J I Lara Capellan; L Cuellar Olmedo; J Martinez Martin; M del Mar Marin; M Garcia Villanueva; F Marin Zarza; H de la Calle Blasco
Journal:  J Neurosurg       Date:  1990-08       Impact factor: 5.115

9.  High-dose methylprednisolone pulse therapy in sarcoidosis.

Authors:  B Wallaert; P Ramon; E C Fournier; P Y Hatron; J F Muir; A B Tonnel; C Voisin
Journal:  Eur J Respir Dis       Date:  1986-04

10.  Partial hypopituitarism and possible hypothalamic involvement in sarcoidosis: report of a case and review of the literature.

Authors:  D L Vesely; A Maldonodo; G S Levey
Journal:  Am J Med       Date:  1977-03       Impact factor: 4.965

View more
  1 in total

Review 1.  Review of physiology, clinical manifestations, and management of hypothalamic obesity in humans.

Authors:  Michelle Lee; Judith Korner
Journal:  Pituitary       Date:  2009       Impact factor: 4.107

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.